Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
J. Bower (Boston, United States of America), J. Shih (Boston, United States of America), V. Seliger (Boston, United States of America), D. Campbell (Boston, United States of America), I. Berhane (Boston, United States of America), R. Wu (Bethesda, United States of America), A. Elbert (Bethesda, United States of America)
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Bower (Boston, United States of America), J. Shih (Boston, United States of America), V. Seliger (Boston, United States of America), D. Campbell (Boston, United States of America), I. Berhane (Boston, United States of America), R. Wu (Bethesda, United States of America), A. Elbert (Bethesda, United States of America). Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data. 2099
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Impact of the British Lung Foundation Active Steps service on patient reported outcomes: concurrent cohort study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021
Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021
Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs) Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006 Source: Eur Respir J 2008; 31: 29-35 Year: 2008
Health resource utilisation due to IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study) Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
Development of the Birmingham Lung Improvement Studies (BLISS) prognostic score for COPD patients in primary care: data from the Birmingham COPD cohort Source: International Congress 2019 – Diagnosis and assessment of airway diseases in primary care Year: 2019
The primary care routine data registry BeoNet: First pilot phase results for COPD research Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018
Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study Source: Eur Respir J 2013; 41: 571-577 Year: 2013
Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK) Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014
Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019
The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018
Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Registries: roles, objectives and registry data study outcomes Source: Eur Respir Monogr 2019; 85: 150-158 Year: 2019
Patient demographics and clinical characteristics in the UK Salford Lung Study (SLS COPD) and the European ACCESS study Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017
The effect of changes in quality of life in patients with lung cancer in the observation period (European Organization for Research and treatment of Cancer) EORTC QLQ-C 30 results of the evaluation and follow-up (AKAYAK-1 project) Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013